Myocardial ischemia as a target for treatment of patients with chronic coronary artery disease

ACC Current Journal Review

Volumn 7, Issue 3, 1998, Pages 23-27

  Pepine, Carl J ^a   Levin, Richard I ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BISOPROLOL;

AMBULATORY MONITORING; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY MONITORING; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; REVIEW; RISK ASSESSMENT; ST SEGMENT; TARGET CELL; TREATMENT OUTCOME;

EID: 0032076499     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(98)00027-0     Document Type: Article

References (13)

1. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life The Atenolol Silent Ischemia Study (ASIST) . Circulation. 90:1994;762-768.
2. Deanfield JE, Shea M, Kensett M, et al. Silent myocardial ischemia due to mental stress. Lancet. 2:1984;1001-1005.
3. Sharaf BL, Williams DO, Miele N, et al. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia Results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study angiographic core laboratory . J Am Coll Cardiol. 29:1997;78-84.
4. Mody FV, Nademanee K, Intrarachot V, et al. Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris Relation to prognostic determinants during exercise stress testing and coronary angiography . J Am Coll Cardiol. 12:1988;1169-1176.
5. Pepine CJ, Sharaf B, Andrews TC, et al. Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot Study. J Am Coll Cardiol. 29:1997;1483-1489.
6. Gill JB, Cairns JA, Roberts RS, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med. 334:1996;65-70.
7. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study two-year follow-up Outcomes of patients randomized to initial strategies of medical therapy versus revascularization . Circulation. 95:1997;2037-2043.
8. Pratt CM, McMahan RP, Goldstein S, et al. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study). Am J Cardiol. 77:1996;1302-1309.
9. von Arnim T, et al. Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis Results of the Total Ischemic Burden Bisoprolol Study (TIBBS) Follow-Up . J Am Coll Cardiol. 28:1996;20-24.
10. Madjlessi-Simon T, Mary-Krause M, Fillette F, et al. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol. 27:1996;1586-1591.
11. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease The Stanford Coronary Risk Intervention Project (SCRIP) . Circulation. 89:1994;975-990.
12. van Boven AJ, Jukema JW, Zwinderman AH, et al. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation. 94:1996;1503-1505.
13. Andrews TC, Raby K, Barry J, et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 95:1997;324-328.